Active, not recruitingPhase 3NCT04544293
Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
Studying Autoimmune pulmonary alveolar proteinosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Savara Inc.
- Principal Investigator
- Bruce Trapnell, MD, MDChildren's Hospital Medical Center, Cincinnati
- Intervention
- Molgramostim(drug)
- Enrollment
- 164 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2027
Study locations (30)
- University Of Arkansas For Medical Services, Little Rock, Arkansas, United States
- UCLA David Geffen School of Medicine, Los Angeles, California, United States
- National Jewish Health, Denver, Colorado, United States
- Yale University, New Haven, Connecticut, United States
- University of Florida Health, Gainesville, Florida, United States
- Emory University, Atlanta, Georgia, United States
- Loyola University, Maywood, Illinois, United States
- University of Maryland Medical Center, Baltimore, Maryland, United States
- Washington University in St. Louis, St Louis, Missouri, United States
- Duke University Medical Center, Durham, North Carolina, United States
- Wake Med Health & Hospital, Raleigh, North Carolina, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
- Cleveland Clinic, Cleveland, Ohio, United States
- University of Pennsylvania Perelman School of Medicine - Pulmonology, Philadelphia, Pennsylvania, United States
- University of Pittsburgh, Pittsburgh, Pennsylvania, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04544293 on ClinicalTrials.govOther trials for Autoimmune pulmonary alveolar proteinosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT06431776Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP).Savara Inc.
- RECRUITINGPHASE4NCT07200544Meloxicam in Mohs Micrographic SurgeryUniversity of Oklahoma
- RECRUITINGPHASE4NCT07102641Post-cesarean Analgesia: Comparing Effectiveness of Staggered v. Simultaneous TherapiesThomas Jefferson University
- ACTIVE NOT RECRUITINGPHASE2NCT06111846Study of Human Bone Marrow Mesenchymal Stem Cells in APAPJiuzhitang Maker (Beijing) Cell Technology Co.,Ltd.
- RECRUITINGPHASE4NCT05425355Intravenous vs Oral Acetaminophen in Postoperative Hip Fracture Adult PatientsUniversity Health Network, Toronto
- RECRUITINGPHASE4NCT03759028Supracondylar Post-Operative Pain StudyUniversity of California, Los Angeles
See all trials for Autoimmune pulmonary alveolar proteinosis →